C-QUR V-Patch Mesh (All sizes and shapes). Intended for use in soft tissue deficiencies.
FDA Device Recall #Z-1938-2013 — Class II — July 19, 2013
Recall Summary
| Recall Number | Z-1938-2013 |
| Classification | Class II — Moderate risk |
| Date Initiated | July 19, 2013 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Atrium Medical Corporation |
| Location | Hudson, NH |
| Product Type | Devices |
| Quantity | 95,286 units |
Product Description
C-QUR V-Patch Mesh (All sizes and shapes). Intended for use in soft tissue deficiencies.
Reason for Recall
Additional Instructions for Use and Storage Conditions as Coated mesh can adhere to the inner packaging liner due to exposure to high humidity conditions
Distribution Pattern
USA (nationwide) including Puerto Rico and the countries of Australia Austria Bahrain Brazil Canada Chile Colombia Dominican Republic Ecuador El Salvador France Germany Great Britain Greece Honduras Hong Kong India Ireland Israel Italy Japan Jordan Korea Malaysia Mexico Netherlands New Zealand Nicaragua Norway Panama Peru Portugal Romania Saudi Arabia Singapore South Africa Spain Sri Lanka Switzerland Taiwan Thailand Turkey and Venezuela.
Lot / Code Information
Product lines with lot number 10405513 and higher
Other Recalls from Atrium Medical Corporation
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0024-2025 | Class II | iCast Covered Stent, 6MMx16MMx120CM, Model Numb... | Sep 9, 2024 |
| Z-1960-2024 | Class II | ADVANTA VXT, 7X70, 1GDS, NH, STR-SW. Single-End... | May 3, 2024 |
| Z-1951-2024 | Class II | ADVANTA VXT, 5X40, 1GDS, NH, STR-SW. Single-End... | May 3, 2024 |
| Z-1989-2024 | Class II | ADVANTA VXT, 6X80, 1GDS, FH, STR-TW. Single-End... | May 3, 2024 |
| Z-1954-2024 | Class II | ADVANTA VXT, 5X50, 1GDS, NH, STR-SW. Single-End... | May 3, 2024 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.